CY 208-243 is a selective dopamine D1 receptor agonist with anti-Parkinson disease activity.

CY 208-243 (2.5 mg / kg; s.c.) pretreatment prevents D-1 antagonist SCH 23390 (0.05 mg / kg; s.c.)-Induced DA release and increased metabolism.

100999-26-6

C19H18N2

274.36

CY 208-243

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years